North America miRNA Sequencing and Assay Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2027 - COVID-19 Impact and Regional Analysis By Product (Library Preparation and Consumables), Technology (Sequencing by Synthesis, Nanopore, and Ion Semiconductor Sequencing), and End User (Research Institute, Academia, and CRO)

No. of Pages: 115    |    Report Code: TIPRE00022179    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
North America miRNA Sequencing and Assay Market

1.             Introduction

1.1       Scope of the Study

1.2       The Insight Partners Research Report Guidance

1.3       Market Segmentation

1.3.1        North America miRNA Sequencing and Assay Market – By Product

1.3.2        North America miRNA Sequencing and Assay Market – By Technology

1.3.3        North America miRNA Sequencing and Assay Market – By End User

1.3.4        North America miRNA Sequencing and Assay Market – By Country

2.             miRNA Sequencing and Assay Market – Key Takeaways

3.             Research Methodology

3.1       Coverage

3.2       Secondary Research

3.3       Primary Research

4.             North America miRNA Sequencing and Assay – Market Landscape

4.1       Overview

4.2       PEST Analysis

4.2.1        North America – PEST Analysis

4.3       Expert Opinions

5.             miRNA Sequencing and Assay Market – Key Market Dynamics

5.1       Key Market Drivers

5.1.1        Widening Range of MicroRNA Applications

5.1.2        Rise in Funding for Genomics Research

5.2       Market Restraints

5.2.1        Challenges Related to Delivery, Efficacy, and Specificity of miRNA-based Therapeutics

5.3       Market Opportunities

5.3.1        Rising Prevalence of Chronic Conditions and Infectious Diseases

5.4       Future Trends

5.4.1        Development and Launch of Innovative Products

5.5       Impact analysis

6.             miRNA Sequencing and Assay Market – North America Analysis

6.1       North America miRNA Sequencing and Assay Market Revenue Forecast and Analysis

7.             miRNA Sequencing and Assay Market Analysis – By Product

7.1       Overview

7.2       miRNA Sequencing and Assay Market Revenue Share, by Product (2019 and 2027)

7.3       Library Preparation

7.3.1        Overview

7.3.2        Library Preparation: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)

7.4       Consumables

7.4.1        Overview

7.4.2        Consumables: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)

8.             miRNA Sequencing and Assay Market Analysis – By Technology

8.1       Overview

8.2       miRNA Sequencing and Assay Market Share, by Technology, 2019 and 2027, (%)

8.3       Sequencing by Synthesis

8.3.1        Overview

8.3.2        Sequencing by Synthesis: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)

8.4       Nanopore

8.4.1        Overview

8.4.2        Nanopore: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)

8.5       Ion Semiconductor Sequencing

8.5.1        Overview

8.5.2        Ion Semiconductor Sequencing: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)

9.             miRNA Sequencing and Assay Market Analysis – By End User

9.1       Overview

9.2       miRNA Sequencing and Assay Market Share, by End User, 2019 and 2027, (%)

9.3       Research Institute

9.3.1        Overview

9.3.2        Research Institute: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)

9.4       Academia

9.4.1        Overview

9.4.2        Academia: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)

9.5       Contract Research Organizations (CROs)

9.5.1        Overview

9.5.2        Contract Research Organizations (CROs): miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)

10.          miRNA Sequencing and Assay Market – North America Analysis

10.1    North America: miRNA Sequencing and Assay Market

10.1.1     Overview

10.1.2     North America: miRNA Sequencing and Assay Market, by Country, 2019 & 2027 (%)

10.1.3     US: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)

10.1.3.1    US: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)

10.1.3.2    US: miRNA Sequencing and Assay Market, by Product, 2018–2027 (USD Million)

10.1.3.3    US: miRNA Sequencing and Assay Market, by Technology, 2018–2027 (USD Million)

10.1.3.4    US: miRNA Sequencing and Assay Market, by End User, 2018–2027 (USD Million)

10.1.4     Canada: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)

10.1.4.1    Canada: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)

10.1.4.2    Canada: miRNA Sequencing and Assay Market, by Product, 2018–2027 (USD Million)

10.1.4.3    Canada miRNA Sequencing and Assay Market, by Technology, 2018–2027 (USD Million)

10.1.4.4    Canada: miRNA Sequencing and Assay Market, by End User, 2018–2027 (USD Million)

10.1.5     Mexico: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)

10.1.5.1    Mexico: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)

10.1.5.2    Mexico: miRNA Sequencing and Assay Market, by Product, 2018–2027 (USD Million)

10.1.5.3    Mexico: miRNA Sequencing and Assay Market, by Technology, 2018–2027 (USD Million)

10.1.5.4    Mexico: miRNA Sequencing and Assay Market, by End User, 2018–2027 (USD Million)

11.          Impact of COVID-19 Pandemic on North America miRNA Sequencing and Assay Market

11.1    North America: Impact Assessment of COVID-19 Pandemic

12.          Industry Landscape

12.1    Overview

12.2    Organic Developments

12.2.1     Overview

12.3    Inorganic Developments

12.3.1     Overview

13.         Company Profiles

13.1    Illumina, Inc.

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2    THERMO FISHER SCIENTIFIC INC.

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3    QIAGEN

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4    Perkin Elmer, Inc.

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5    Takara Bio Inc.

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6    New England Biolabs

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7    Norgen Biotek Corp

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8    TriLink BioTechnologies Inc.

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

13.9    Lexogen GmbH

13.9.1     Key Facts

13.9.2     Business Description

13.9.3     Products and Services

13.9.4     Financial Overview

13.9.5     SWOT Analysis

13.9.6     Key Developments

13.10 Oxford Nanopore Technologies

13.10.1   Key Facts

13.10.2   Business Description

13.10.3   Products and Services

13.10.4   Financial Overview

13.10.5   SWOT Analysis

13.10.6   Key Developments

14.          Appendix

14.1    About The Insight Partners

14.2    Glossary of Terms

LIST OF TABLES

Table 1.             US miRNA Sequencing and Assay Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 2.             US miRNA Sequencing and Assay Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 3.             US miRNA Sequencing and Assay Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 4.             Canada miRNA Sequencing and Assay Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 5.             Canada miRNA Sequencing and Assay Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 6.             Canada miRNA Sequencing and Assay Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 7.             Mexico miRNA Sequencing and Assay Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 8.             Mexico miRNA Sequencing and Assay Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 9.             Mexico miRNA Sequencing and Assay Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 10.          Organic Developments Done by Companies

Table 11.          Inorganic Developments Done by Companies

Table 12.          Glossary of Terms, miRNA Sequencing and Assay Market

LIST OF FIGURES

Figure 1.           miRNA Sequencing and Assay Market Segmentation

Figure 2.           miRNA Sequencing and Assay Market Segmentation, By Country

Figure 3.           miRNA Sequencing and Assay Market Overview

Figure 4.           Library Preparation Segment by Product Segment Expected to Witness Rapid Growth

Figure 5.           North America miRNA Sequencing and Assay Market – Leading Country Markets (US$ Million)

Figure 6.           North America PEST Analysis

Figure 7.           miRNA Sequencing and Assay Market Impact Analysis of Driver and Restraints

Figure 8.           North America miRNA Sequencing and Assay Market – Revenue Forecast and Analysis – 2019- 2027

Figure 9.           miRNA Sequencing and Assay Market Revenue Share, by Product (2019 and 2027)

Figure 10.        Library Preparation: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)

Figure 11.        Consumables: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)

Figure 12.        miRNA Sequencing and Assay Market Share, by Technology, 2019 and 2027 (%)

Figure 13.        Sequencing by Synthesis: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)

Figure 14.        Nanopore: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)

Figure 15.        Ion Semiconductor Sequencing: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)

Figure 16.        miRNA Sequencing and Assay Market Share, by End User, 2019 and 2027 (%)

Figure 17.        Research Institute: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)

Figure 18.        Academia: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)

Figure 19.        Contract Research Organizations (CROs): miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)

Figure 20.        North America: miRNA Sequencing and Assay Market, by Key Country – Revenue (2019) (USD Million)

Figure 21.        North America: miRNA Sequencing and Assay Market, by Country, 2019 & 2027 (%)

Figure 22.        US: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)

Figure 23.        Canada: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)

Figure 24.        Mexico: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)

Figure 25.        Impact of COVID-19 Pandemic in North American Country Markets

 

The List of Companies - North America miRNA Sequencing and Assay Market

  1. Illumina, Inc
  2. THERMO FISHER SCIENTIFIC INC.
  3. QIAGEN
  4. Perkin Elmer, Inc.
  5. Takara Bio Inc.
  6. New England Biolabs
  7. Norgen Biotek Corp
  8. TriLink BioTechnologies Inc.
  9. Lexogen GmbH
  10. Oxford Nanopore Technologies